Diana Tait Selected Research

Carboplatin (JM8)

10/2018

Cisplatin Substitution with Carboplatin During Radical Chemoradiotherapy for Oesophagogastric Carcinoma: Outcomes from a Tertiary Centre.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diana Tait Research Topics

Disease

17	Rectal Neoplasms (Rectal Cancer) 01/2020 - 02/2006
14	Neoplasms (Cancer) 11/2020 - 02/2006
7	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 02/2004
3	Breast Neoplasms (Breast Cancer) 11/2020 - 03/2007
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2012 - 04/2006
2	Adenocarcinoma 09/2011 - 06/2008
1	COVID-19 01/2021
1	Carcinoma (Carcinomatosis) 10/2018
1	Pelvic Neoplasms 09/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2011
1	Opportunistic Infections (Opportunistic Infection) 11/2011
1	Brain Neoplasms (Brain Tumor) 12/2008
1	Neoplasm Metastasis (Metastasis) 12/2008
1	Sigmoid Neoplasms 01/2008
1	Margins of Excision 06/2006
1	Primitive Neuroectodermal Tumors (PNET) 05/2006
1	Pain (Aches) 04/2006
1	Fecal Incontinence 04/2006
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 04/2006
1	Colitis 02/2006
1	Pulmonary Embolism 02/2006
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2006
1	Chest Pain (Chest Pains) 02/2006
1	Sudden Death 02/2006
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 06/2005
1	Infections 02/2004
1	Erythema 02/2004
1	Diarrhea 02/2004
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2002

Drug/Important Bio-Agent (IBA)

5	Cetuximab (Erbitux)FDA Link 03/2016 - 05/2012
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2016 - 02/2006
4	Capecitabine (Xeloda)FDA Link 01/2016 - 02/2006
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 03/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2013 - 09/2012
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2013 - 09/2012
2	Fluorouracil (Carac)FDA LinkGeneric 07/2005 - 02/2004
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 11/2020
1	Interleukin-4 (Interleukin 4)IBA 11/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Circulating Tumor DNAIBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 10/2018
1	Cisplatin (Platino)FDA LinkGeneric 10/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Coenzyme A (CoA)IBA 09/2012
1	Oxidoreductases (Dehydrogenase)IBA 09/2012
1	Peptides (Polypeptides)IBA 12/2006
1	AntidiarrhealsIBA 04/2006
1	Leucovorin (Folinic Acid)FDA Link 07/2005
1	Pentoxifylline (Trental)FDA LinkGeneric 06/2005
1	alpha-Tocopherol FDA Link 06/2005
1	AntigensIBA 04/2004
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 02/2004
1	Prednisone (Sone)FDA LinkGeneric 09/2002
1	Vincristine (Oncovin)FDA LinkGeneric 09/2002
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 09/2002
1	Methotrexate (Mexate)FDA LinkGeneric 09/2002
1	Melphalan (Alkeran)FDA LinkGeneric 09/2002

Therapy/Procedure

18	Radiotherapy 11/2020 - 06/2005
11	Chemoradiotherapy 10/2018 - 02/2006
10	Therapeutics 01/2021 - 09/2002
8	Neoadjuvant Therapy 01/2018 - 06/2006
7	Drug Therapy (Chemotherapy) 01/2017 - 04/2006
2	Induction Chemotherapy 11/2013 - 09/2011
2	Adjuvant Chemotherapy 07/2005 - 04/2004
1	Minimally Invasive Surgical Procedures 01/2021
1	Salvage Therapy 01/2017
1	Highly Active Antiretroviral Therapy (HAART) 11/2011
1	Combination Drug Therapy (Combination Chemotherapy) 03/2010
1	Maintenance Chemotherapy 09/2002
1	Transplantation 09/2002
1	Autologous Transplantation 09/2002